About
Alma Therapeutics is developing a capsule for the oral delivery of complex and biologic molecules. The company's Mobius Capsule is a novel drug delivery platform for the oral delivery of complex molecules and biologics such as peptides, proteins, and antibodies.
Alma's capsule provides a platform for the oral delivery of therapeutic proteins and peptides that possess poor oral bioavailability, necessitating administration via injections.
The company’s technology utilizes a microneedle-array approach for advanced oral delivery. This is a novel needle‐free alternative to injectable drugs that can enhance quality of life for millions of people requiring chronic administration of injectable drugs.
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is Alma Therapeutics' core product?
- Alma Therapeutics is developing the Mobius Capsule, a novel drug delivery platform for the oral delivery of complex and biologic molecules such as peptides, proteins, and antibodies.
- What problem does Alma Therapeutics' technology aim to solve?
- Alma Therapeutics' technology aims to provide a needle-free, oral alternative to injectable drugs for therapeutic proteins and peptides that currently have poor oral bioavailability.
- When was Alma Therapeutics founded?
- Alma Therapeutics was founded in February 2017.
- Where is Alma Therapeutics headquartered?
- Alma Therapeutics is headquartered in Petah Tikva, Israel.
- What is the current funding stage of Alma Therapeutics?
- Alma Therapeutics is currently in the Pre-Funding stage.
- How many employees does Alma Therapeutics have?
- Alma Therapeutics has 6 employees.
- Who is a founder of Alma Therapeutics?
- Oz Cabiri is a founder of Alma Therapeutics.
- What is Alma Therapeutics' primary sector?
- Alma Therapeutics' primary sector is Health Tech & Life Sciences, specifically focusing on Pharma & Medical Biotechnology and Drug Delivery.